Zhou X - Search Results

1

Regulation of PCGEM1 by p54/nrb in prostate cancer.

Ho TT, Huang J, Zhou N, Zhang Z, Koirala P, Zhou X, Wu F, Ding X, Mo YY. Ho TT, et al. Among authors: zhou x, zhou n. Sci Rep. 2016 Sep 29;6:34529. doi: 10.1038/srep34529. Sci Rep. 2016. PMID: 27682980 Free PMC article.

2

Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans.

Dias SJ, Zhou X, Ivanovic M, Gailey MP, Dhar S, Zhang L, He Z, Penman AD, Vijayakumar S, Levenson AS. Dias SJ, et al. Among authors: zhou x. Sci Rep. 2013;3:2331. doi: 10.1038/srep02331. Sci Rep. 2013. PMID: 23900262 Free PMC article.

3

Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues.

Wang C, Mao J, Redfield S, Mo Y, Lage JM, Zhou X. Wang C, et al. Among authors: zhou x. Exp Mol Pathol. 2014 Oct;97(2):259-65. doi: 10.1016/j.yexmp.2014.07.013. Epub 2014 Jul 30. Exp Mol Pathol. 2014. PMID: 25084322 Free PMC article.

4

Regulation of androgen receptor splice variant AR3 by PCGEM1.

Zhang Z, Zhou N, Huang J, Ho TT, Zhu Z, Qiu Z, Zhou X, Bai C, Wu F, Xu M, Mo YY. Zhang Z, et al. Among authors: zhou x, zhou n. Oncotarget. 2016 Mar 29;7(13):15481-91. doi: 10.18632/oncotarget.7139. Oncotarget. 2016. PMID: 26848868 Free PMC article.

5

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader.

Hu X, Peng WX, Zhou H, Jiang J, Zhou X, Huang D, Mo YY, Yang L. Hu X, et al. Among authors: zhou h, zhou x. Cell Death Differ. 2020 Jun;27(6):1782-1794. doi: 10.1038/s41418-019-0461-z. Epub 2019 Dec 5. Cell Death Differ. 2020. PMID: 31804607 Free PMC article.

6

The association of prostatic lipids with progression, racial disparity and discovery of biomarkers in prostate cancer.

Zhou X, Mao J, Peng W, Chen Z, Mei H, Kyle P, Mo Y, Allen TC. Zhou X, et al. Transl Oncol. 2021 Dec;14(12):101218. doi: 10.1016/j.tranon.2021.101218. Epub 2021 Sep 10. Transl Oncol. 2021. PMID: 34509951 Free PMC article.

7

Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells.

Espinoza I, Sakiyama MJ, Ma T, Fair L, Zhou X, Hassan M, Zabaleta J, Gomez CR. Espinoza I, et al. Among authors: zhou x. Front Oncol. 2016 Jun 15;6:144. doi: 10.3389/fonc.2016.00144. eCollection 2016. Front Oncol. 2016. PMID: 27379206 Free PMC article.

8

PIK3CG Is a Potential Therapeutic Target in Androgen Receptor-Indifferent Metastatic Prostate Cancer.

Chung WC, Zhou X, Atfi A, Xu K. Chung WC, et al. Among authors: zhou x. Am J Pathol. 2020 Nov;190(11):2194-2202. doi: 10.1016/j.ajpath.2020.07.013. Epub 2020 Aug 15. Am J Pathol. 2020. PMID: 32805234 Free article.

9

A retrospective study on pathologic features and racial disparities in prostate cancer.

Bigler SA, Pound CR, Zhou X. Bigler SA, et al. Among authors: zhou x. Prostate Cancer. 2011;2011:239460. doi: 10.1155/2011/239460. Epub 2011 Oct 31. Prostate Cancer. 2011. PMID: 22135747 Free PMC article.

10

Expression of trefoil factor 3 is decreased in colorectal cancer.

Espinoza I, Agarwal S, Reddy A, Shenoy V, Subramony C, Sakiyama M, Fair L, Poosarla T, Zhou X, Shannon Orr W, Lahr C, Bae S, Al Diffalha S, Manne U, Gomez CR. Espinoza I, et al. Among authors: zhou x. Oncol Rep. 2021 Jan;45(1):254-264. doi: 10.3892/or.2020.7829. Epub 2020 Oct 30. Oncol Rep. 2021. PMID: 33210724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48,475 results

Search Page